ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,479Medicare Part D Prescriptions Filled, Including Refills

Rank: 130 out of 1844

$699K Total Retail Price of All Prescriptions

Rank: 151 out of 1844

452 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,149 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 744 548 S3 1 2
FUROSEMIDE 384 357 2 7
SIMVASTATIN 339 326 3 3
LISINOPRIL 333 238 4 4
POTASSIUM CHLORIDE 328 308 5 16
AMLODIPINE BESYLATE 323 291 6 6
OMEPRAZOLE 302 265 7 5
LEVOTHYROXINE SODIUM 276 258 8 1
ZOLPIDEM TARTRATE 248 168 9 23
METFORMIN HCL 232 174 10 8
ISOSORBIDE MONONITRATE ER 227 188 11 59
ATENOLOL 223 201 12 17
NAMENDA 218 218 13 33
WARFARIN SODIUM 211 167 14 13
DONEPEZIL HCL 177 177 15 26
GLIMEPIRIDE 174 158 16 35
METOPROLOL SUCCINATE 172 129 17 14
CITALOPRAM HBR 171 130 18 19
METOPROLOL TARTRATE 166 149 19 11
TAMSULOSIN HCL 162 143 20 27
NEXIUM 150 95 21 31
PANTOPRAZOLE SODIUM 150 148 21 32
ATORVASTATIN CALCIUM 145 122 23 12
BUMETANIDE 128 115 24 121
HYDROCHLOROTHIAZIDE 118 69 25 9
DIGOXIN 113 106 26 67
PRAVASTATIN SODIUM 113 82 26 10
ALLOPURINOL 109 96 28 29
CIPROFLOXACIN HCL 99 82 29 62
FENTANYL 92 61 S2 30 66
ESCITALOPRAM OXALATE 92 92 30 52
SERTRALINE HCL 87 67 32 21
GABAPENTIN 86 58 33 15
METOCLOPRAMIDE HCL 80 75 34 148
CLOPIDOGREL 72 64 35 34
CYMBALTA 72 31 35 36
PREDNISONE 71 53 37 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 71 37 20
LYRICA 70 45 39 92
CARVEDILOL 68 68 40 22
PROAIR HFA 67 22 41 45
NAPROXEN 67 41 41 87
QUETIAPINE FUMARATE 65 55 43 82
HYDRALAZINE HCL 65 47 43 120
SUCRALFATE 59 45 45 183
MELOXICAM 59 48 45 28
CYCLOBENZAPRINE HCL 57 35 R 47 53
PLAVIX 57 48 47 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 54 49 73
HUMALOG 56 54 49 114
VERAPAMIL ER 53 53 51 98
AMITRIPTYLINE HCL 52 42 R 52 72
PROPRANOLOL HCL 51 51 53 129
TRAZODONE HCL 50 28 54 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.